Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cardiac and kidney benefits of empagliflozin in heart failure across the spectrum of kidney function: Insights from the EMPEROR-Preserved trial.
Sharma A, Ferreira JP, Zannad F, Pocock SJ, Filippatos G, Pfarr E, Petrini M, Kraus BJ, Wanner C, Packer M, Butler J, Anker SD. Sharma A, et al. Among authors: kraus bj. Eur J Heart Fail. 2023 Aug;25(8):1337-1348. doi: 10.1002/ejhf.2857. Epub 2023 May 4. Eur J Heart Fail. 2023. PMID: 37062851 Free article. Clinical Trial.
A Janus-headed electrolyte and 'RALES' disease'.
Kraus D, Wanner C, Kraus BJ. Kraus D, et al. Among authors: kraus bj. ESC Heart Fail. 2017 Aug;4(3):195-197. doi: 10.1002/ehf2.12173. Epub 2017 Jun 26. ESC Heart Fail. 2017. PMID: 28772052 Free PMC article. No abstract available.
Characterization and implications of the initial estimated glomerular filtration rate 'dip' upon sodium-glucose cotransporter-2 inhibition with empagliflozin in the EMPA-REG OUTCOME trial.
Kraus BJ, Weir MR, Bakris GL, Mattheus M, Cherney DZI, Sattar N, Heerspink HJL, Ritter I, von Eynatten M, Zinman B, Inzucchi SE, Wanner C, Koitka-Weber A. Kraus BJ, et al. Kidney Int. 2021 Mar;99(3):750-762. doi: 10.1016/j.kint.2020.10.031. Epub 2020 Nov 10. Kidney Int. 2021. PMID: 33181154 Free article. Clinical Trial.
Cardio/Kidney Composite End Points: A Post Hoc Analysis of the EMPA-REG OUTCOME Trial.
Ferreira JP, Kraus BJ, Zwiener I, Lauer S, Zinman B, Fitchett DH, Koitka-Weber A, George JT, Ofstad AP, Wanner C, Zannad F. Ferreira JP, et al. Among authors: kraus bj. J Am Heart Assoc. 2021 Apr 6;10(7):e020053. doi: 10.1161/JAHA.120.020053. Epub 2021 Mar 23. J Am Heart Assoc. 2021. PMID: 33754809 Free PMC article. Clinical Trial.
Early changes in estimated glomerular filtration rate post-initiation of empagliflozin in EMPEROR-Reduced.
Zannad F, Ferreira JP, Gregson J, Kraus BJ, Mattheus M, Hauske SJ, Butler J, Filippatos G, Wanner C, Anker SD, Pocock SJ, Packer M; EMPEROR-Reduced Trial Committees and Investigators. Zannad F, et al. Among authors: kraus bj. Eur J Heart Fail. 2022 Oct;24(10):1829-1839. doi: 10.1002/ejhf.2578. Epub 2022 Jul 7. Eur J Heart Fail. 2022. PMID: 35711093 Free article. Clinical Trial.
28 results